the anturane reinfarction trial is a randomized , double-blind , multicenter clinical trial comparing sulfinpyrazone ( 200 mg four times a day ) and placebo in the prevention of cardiac mortality among patients with a recent documented myocardial infarction .
C0591099
anturane
C0038742
sulfinpyrazone